Early empiric antibiotic use in COVID-19 patients: results from the international VIRUS registry

Early empiric antibiotic use in COVID-19 patients: results from the international VIRUS registry

Objectives: COVID-19 escalated inappropriate antibiotic use. We determined the distribution of pathogens causing community-acquired co-infections, the rate, and factors associated with early empiric antibiotic (EEAB) treatment among hospitalized COVID-19 patients. Methods: The Society of Critical Ca...

Full description

Bibliographic Details
Main Authors: Uluhan Sili, Aysun Tekin, Huseyin Bilgin, Syed Anjum Khan, Juan Pablo Domecq, Girish Vadgaonkar, Smitha S. Segu, Puneet Rijhwani, Umamaheswara Raju, Krishna Mohan Surapaneni, Igor Zabolotskikh, Dina Gomaa, Valerie M. Goodspeed, Pinar Ay
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
Pandemic
Empiric antibiotic treatment
Antimicrobial stewardship
Antibiotic resistance
Bacterial co-infection
Online Access:http://www.sciencedirect.com/science/article/pii/S120197122300810X

Internet

http://www.sciencedirect.com/science/article/pii/S120197122300810X

Similar Items